Hyaline

Lifshitz Law Firm, P.C. Announces Investigations of Ardelyx Inc. (NASDAQGM: ARDX), Hyzon Motors Inc. (NASDAQ: HYZN), View, Inc. (NASDAQGM: VIEW). and Zymergen Inc. (NASDAQGS: ZY)

Retrieved on: 
Wednesday, April 13, 2022
Lists of schools in England, Hewlett, Hyaline, FDA, Company, Telephone, Advertising, View, Pharmaceutical industry, Online shopping

If you are an ARDX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are an ARDX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Hyzon investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Zymergen investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

Lifshitz Law Firm, P.C. Announces Investigations of Activision Blizzard, Inc. (NASDAQGS: ATVI), Ardelyx Inc. (NASDAQGM: ARDX), Iterum Therapeutics plc (NASDAQCM: ITRM), and Zymergen Inc. (NASDAQGS: ZY)

Retrieved on: 
Thursday, December 23, 2021
NDA, California Department of Fair Employment and Housing, Risk, Hewlett, Activision Blizzard, ITRM, Telephone, Advertising, Adult, Hyaline, California Department, Company, Law firm, Lists of schools in England, Activision, P.C, Woman, FDA, Online shopping, Pharmaceutical industry, Housing

If you are an Activision Blizzard investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are an Activision Blizzard investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are an ARDX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Zymergen investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymergen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, December 16, 2021
Defendant, GLOBE, Hyaline, Register, Telephone, ZY, Company, Registration statement, NASDAQ, P.C, Property management

Our investigation concerns whether the board of directors of Zymergen have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Zymergen have breached their fiduciary duties to the company.
  • The complaint alleges that the Registration Statement was materially false and misleading and omitted to state material adverse facts.
  • is a nationally recognized law firm with offices in New York and California.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Zymergen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 4, 2021
Legal, Professional Services, Hyaline, P.C, Jeanne Eagels (film), Register, Registration statement, Defendant, ZY, NASDAQ, Telephone, Company, Private investigator, Property management

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymergen Inc. (NASDAQ: ZY) on behalf of long-term stockholders following a class action complaint that was filed against Sequential on August 4, 2021.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymergen Inc. (NASDAQ: ZY) on behalf of long-term stockholders following a class action complaint that was filed against Sequential on August 4, 2021.
  • Our investigation concerns whether the board of directors of Sequential have breached their fiduciary duties to the company.
  • The complaint alleges that the Registration Statement was materially false and misleading and omitted to state material adverse facts.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behalf of Investors

Retrieved on: 
Thursday, November 11, 2021
Legal, Professional Services, NASDAQ, Law, Hyaline, Twitter, Suite, Company, IPO, Management

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Zymergen Inc. (Zymergen or the Company) (NASDAQ: ZY ) concerning whether the board breached its fiduciary duties to shareholders.

Key Points: 
  • The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Zymergen Inc. (Zymergen or the Company) (NASDAQ: ZY ) concerning whether the board breached its fiduciary duties to shareholders.
  • In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.
  • As a result, Zymergen no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Zymergen Inc. (ZY) on Behalf of Investors

Retrieved on: 
Wednesday, November 10, 2021
Legal, Professional Services, GPM, NASDAQ, Hyaline, News, Company, IPO, Security (finance)

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.
  • As a result, Zymergen no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zymergen, Inc. (ZY)

Retrieved on: 
Wednesday, November 10, 2021
Registration statement, District court, Register, Hyaline, ZY, Company, Complaint, GLOBE, IPO, Security (finance)

Investors who purchased or otherwise acquired shares of Zymergen pursuant and/or traceable to the Registration Statement issued in connection with Zymergens April 2021 IPO should contact the Firm.

Key Points: 
  • Investors who purchased or otherwise acquired shares of Zymergen pursuant and/or traceable to the Registration Statement issued in connection with Zymergens April 2021 IPO should contact the Firm.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .
  • Please visit our website at http://www.gme-law.com for more information about the firm.

Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, November 3, 2021
Biology, Chemistry, GAAP, Mission statement, Partnership, Total, Private Securities Litigation Reform Act, Drug discovery, Electronics, Hand, Agriculture, Sumitomo Chemical, U.S. Securities and Exchange Commission, SEC, Review, Forward-looking statement, Software, Hyaline, Company, Program, Acquisition, Commercial, D, GLOBE, Enzyme, Automation, Nitrogen fixation, Risk management, Pharmaceutical industry, Cryptocurrency

EMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company), a leading biofacturing company, today reported preliminary financial results for the third quarter ended September 30, 2021.

Key Points: 
  • EMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (Zymergen or the Company), a leading biofacturing company, today reported preliminary financial results for the third quarter ended September 30, 2021.
  • In addition, the preliminary estimates should not be viewed as a substitute for full quarter financial statements prepared in accordance with GAAP.
  • There is a possibility that Zymergens third quarter financial results could vary materially from these preliminary estimates.
  • Zymergen will host a conference call to discuss the preliminary third quarter 2021 financial results after market close on Wednesday, November 3, 2021, at 1:30 pm Pacific Time / 4:30 pm Eastern Time.

DEADLINE ALERT for ZY, YALA, and LIVE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, October 4, 2021
Live, Suite, FY, Income, GLOBE, Twitter, Defendant, Acquisition, Company, Registration statement, Register, Hyaline, Law, Investment, Time, Lists of schools in England, Security (finance), Mail

LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Registration Statement was materially false and misleading and omitted to state material adverse facts.
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Zymergen Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, October 4, 2021
News, ZY, NASDAQ, Court, Defendant, Company, District court, Registration statement, Register, Hyaline, IPO, Telephone, P.C, GLOBE, Security (finance), Risk management

Investors have until October 4, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 4, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In April 2021, Zymergen completed its IPO, selling approximately 18.5 million shares of common stock at $31 per share.
  • As a result, Zymergen no longer expects product revenue in 2021, and expects product revenue to be immaterial in 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.